drugset / Trial / NCT07513571

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults

NCT07513571

Phase 1 Recruiting 32 enrolled AstraZeneca
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose this study is to measure the impact of laroprovstat (AZD0780) on the pharmacokinetics (PK) of AZD4954 and the impact of AZD4954 on the PK of laroprovstat in healthy male and female participants.

Timeline

Start
2026-04-10
Primary completion
2026-07-09
Completion
2026-07-09

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD4954 Unknown Oral
Subject Laroprovstat Small molecule Oral

Indications

No indication recorded.